Qube Research & Technologies (QRT)
BBIO icon

Qube Research & Technologies (QRT)’s BridgeBio Pharma BBIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.2M Buy
+727,205
New +$50.9M 0.05% 472
2026
Q1 		– Sell
-114,156
Closed -$8.73M – 3536
2025
Q4 		$8.73M Sell
114,156
-269,022
-70% -$17.7M 0.01% 1434
2025
Q3 		$19.9M Sell
383,178
-181,038
-32% -$8.83M 0.02% 896
2025
Q2 		$24.4M Sell
564,216
-196,258
-26% -$7.14M 0.02% 782
2025
Q1 		$26.3M Buy
760,474
+747,707
+5,857% +$25.2M 0.03% 627
2024
Q4 		$350K Buy
+12,767
New +$330K ﹤0.01% 2644
2024
Q2 		– Sell
-2,432
Closed -$75.2K – 3815
2024
Q1 		$75.2K Buy
2,432
+2,327
+2,216% +$79.1K ﹤0.01% 3398
2023
Q4 		$4.24K Buy
+105
New +$3.15K ﹤0.01% 3737
2023
Q3 		– Sell
-53,473
Closed -$920K – 4089
2023
Q2 		$920K Sell
53,473
-290,312
-84% -$4.37M ﹤0.01% 1339
2023
Q1 		$5.7M Buy
343,785
+203,433
+145% +$2.37M 0.02% 630
2022
Q4 		$1.07M Buy
140,352
+25,397
+22% +$243K 0.01% 1203
2022
Q3 		$1.14M Buy
+114,955
New +$1.19M 0.01% 1152
2022
Q1 		– Sell
-16,928
Closed -$282K – 2448
2021
Q4 		$282K Buy
+16,928
New +$716K ﹤0.01% 1830
2021
Q2 		– Sell
-23,985
Closed -$1.48M – 2264
2021
Q1 		$1.48M Buy
+23,985
New +$1.57M 0.02% 708
2020
Q4 		– Sell
-6,314
Closed -$237K – 1806
2020
Q3 		$237K Sell
6,314
-6,937
-52% -$218K ﹤0.01% 1337
2020
Q2 		$432K Buy
+13,251
New +$404K 0.01% 1177

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BBIO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 727,205 shares worth $54.2M. The stake represents 0.05% of the portfolio and ranks #472 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in BBIO as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in BBIO in Q2 2020 and has held it in 16 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Qube Research & Technologies (QRT) held 727,205 shares of BridgeBio Pharma worth $54.2M as of Q2 2026.
  • BridgeBio Pharma was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • BridgeBio Pharma made up 0.05% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #472 holding.
  • Qube Research & Technologies (QRT) first reported a position in BridgeBio Pharma in Q2 2020 and has held it in 16 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.